Perle Bioscience Overview

  • Founded
  • 2013
Founded
  • Status
  • Out of Business
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Out of Business

Perle Bioscience General Information

Description

Provider of medicinal research and development services intended to revolutionize diabetes treatment. The company's research has discovered new human beta regeneration peptides that regenerate insulin producing cells in the pancreas, enabling diabetic patients to eliminate their dependency on insulin shots.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 520 Folly Road
  • Suite P-212
  • Charleston, SC 29412
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Perle Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 10-Nov-2016 00.000 Completed Out of Business
3. Early Stage VC (Series B) 07-Dec-2015 00.00 00.000 000.00 Completed Clinical Trials - Phase 3
2. Early Stage VC (Series A) 28-Jul-2014 $2.93M $2.93M 000.00 Completed Startup
1. Equity Crowdfunding 05-Sep-2013 $2M Completed Startup
To view Perle Bioscience’s complete valuation and funding history, request access »

Perle Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 000,000 00.000000 00.0 00.0 00 00.0 0.000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view Perle Bioscience’s complete cap table history, request access »

Perle Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of medicinal research and development services intended to revolutionize diabetes treatment. The company's rese
Biotechnology
Charleston, SC
6 As of 2015
00.000
00000000 00 00.000

00000000

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute
0000000000000
Lexington, MA
00 As of 0000
00000
00000000 00000

0000000

enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conseq
0000 000000000
Boston, MA
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Perle Bioscience Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pulmatrix Formerly VC-backed Lexington, MA 00 00000 00000000 00000
0000000 Venture Capital-Backed Boston, MA 00 00000 00000000000 00000
00000000 000000000 Corporate Backed or Acquired San Diego, CA 000 00000 000000&0
000000 Formerly VC-backed Austin, TX 00 00000 000000000 00000
00000 000000000000 Formerly VC-backed San Diego, CA 000 00000 000000 - 000 00000
You’re viewing 5 of 7 competitors. Get the full list »

Perle Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial